Hemodialysis has an adverse impact on the immunological, nutritional, and emotional status of patients. The biochemical markers of inflammation and nutrition were studied as well as the relationship of these factors to emotional symptoms.
Method:
One hundred and ninety-five patients undergoing hemodialysis were enrolled. The mean age was 58.5 years. Emotional symptoms were assessed using the Mini International Neuropsychiatric Interview, Hospital Anxiety and Depression Scale, Chalder Fatigue Scale, and Short-form Health-related Quality of Life. Venus blood was collected for laboratory assessment of serum hemoglobin, albumin, ferritin, C-reactive protein, interleukin (IL) 1β), IL-6, and tumor necrosis factor a.
Results:
Among the 195 subjects (92 men and 103 women), 47 (24.1%) fulfilled the criteria for a major depressive disorder (MDD). The IL-6 level in patients with a MDD was significantly higher than in the patients without a MDD. Significant correlation was observed among the following factors: IL-6, fatigue, and quality of life for both physical and mental components. The albumin levels showed a significant correlation with the IL-6 and depression scores.
Conclusions:
These results show that the serum levels of albumin and IL-6 might be laboratory markers associated with the expression of emotional symptoms in patients undergoing hemodialysis. Prospective studies are needed to determine the causal relationships among these variables.
KimmelPL. Psychosocial factors in dialysis patients. Kidney International2001;59:1599–1613.
2.
DrayerRAPirainoBReynoldsCF3rdHouckPRMazumdarSBernardiniJShearMKRollmanBL. Characteristics of depression in hemodialysis patients: Symptoms, quality of life and mortality risk. General Hospital Psychiatry2006;28:306–312.
3.
ChilcotJWellstedDDa Silva-GaneMFarringtonK. Depression on dialysis. Nephron Clinical Practice2008;108:c256–c264.
4.
CukorDCoplanJBrownCPetersonRAKimmelPL. Course of depression and anxiety diagnosis in patients treated with hemodialysis: A 16-month follow-up. Clinical Journal of the American Society of Nephrology2008;3:1752–1758.
5.
JhambMWeisbordSDSteelJLUnruhM. Fatigue in patients receiving maintenance dialysis: A review of definitions, measures, and contributing factors. American Journal of Kidney Diseases2008;52:353–365.
6.
KaoTWLaiMSTsaiTJJanCFChieWCChenWY. Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: A multicenter study. Artificial Organs2009;33:61–68.
7.
KurellaMKimmelPLYoungBSChertowGM. Suicide in the United States end-stage renal disease program. Journal of the American Society of Nephrology2005;16:774–781.
8.
KooJRYoonJWKimSGLeeYKOhKHKimGHKimHJChaeDWNohJWLeeSKSonBK. Association of depression with malnutrition in chronic hemodialysis patients. American Journal of Kidney Diseases2003;41:1037–1042.
9.
DoganEErkocREryonucuBSayarliogluHAgargunMY. Relation between depression, some laboratory parameters, and quality of life in hemodialysis patients. Renal Failure2005;27:695–699.
10.
PertosaGGrandalianoGGesualdoLSchenaFP. Clinical relevance of cytokine production in hemodialysis. Kidney International Supplement2000;76:S104–S111.
11.
AgrawalSGollapudiPElahimehrRPahlMVVaziriND. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrology Dialysis Transplantation2010;25:737–746.
12.
CapuronLMillerAH. Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacology & Therapeutics2011;130:226–238.
13.
WichersMMaesM. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology2002; 5:375–388.
14.
IrwinMRMillerAH. Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity2007;21:374–383.
15.
MillerDBO'CallaghanJP. Depression, cytokines, and glial function. Metabolism2005;54:33–38.
16.
HowrenMBLamkinDMSulsJ. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine2009;71:171–186.
17.
O'DonovanAHughesBMSlavichGMLynchLCroninMTO'FarrellyCMaloneKM. Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion-biology relationships. Brain, Behavior, and Immunity2010;24:1074–1077.
18.
BossolaMLucianiGGiungiSTazzaL. Anorexia, fatigue, and plasma interleukin-6 levels in chronic hemodialysis patients. Renal Failure2010;32:1049–1054.
19.
KimYKLeeSWKimSHShimSHHanSWChoiSHLeeBH. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry2008;32:356–361.
20.
LindqvistDJanelidzeSHagellPErhardtSSamuelssonMMinthonLHanssonOBjorkqvistMTraskman-BendzLBrundinL. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biological Psychiatry2009;66:287–292.
21.
JanelidzeSMatteiDWestrinATraskman-BendzLBrundinL. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain, Behavior, and Immunity2011;25:335–339.
22.
StenvinkelPHeimburgerOPaultreFDiczfalusyUWangTBerglundLJogestrandT. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International1999;55:1899–1911.
23.
BossolaMLucianiGTazzaL. Fatigue and its correlates in chronic hemodialysis patients. Blood Purification2009;28:245–252.
24.
HuangTLLeeCT. Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression. Psychiatry Research2007;152:277–280.
25.
CziraMELindnerAVSzeifertLMolnarMZFornadiKKelemenALaszloGMucsiIKeszeiAPKennedySHNovakM. Association between the Malnutrition-Inflammation Score and depressive symptoms in kidney transplanted patients. General Hospital Psychiatry2011;33:157–165.
26.
ChenCKTsaiYCHsuHJWuIWSunCYChouCCLeeCCTsaiCRWuMSWangLJ. Depression and suicide risk in hemodialysis patients with chronic renal failure. Psychosomatics2010;51:528–528, e526.
27.
SheehanDVLecrubierYSheehanKHAmorimPJanavsJWeillerEHerguetaTBakerRDunbarGC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry1998;59(Suppl 20):22–33; quiz 34–57.
28.
KuoCJTangHSTsayCJLinSKHuWHChenCC. Prevalence of psychiatric disorders among bereaved survivors of a disastrous earthquake in Taiwan. Psychiatric Service2003;54:249–251.
29.
OlssonIMykletunADahlAA. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry2005;5:46.
30.
LoosmanWLSiegertCEKorzecAHonigA. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. British Journal of Clinical Psychology2010;49:507–516.
31.
LeungCMWingYKKwongPKLoAShumK. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatrica Scandinavica1999;100:456–461.
32.
ChalderTBerelowitzGPawlikowskaTWattsLWesselySWrightDWallaceEP. Development of a fatigue scale. Journal of Psychosomatic Research1993;37:147–153.
33.
WongWSFieldingR. Construct validity of the Chinese version of the Chalder Fatigue Scale in a Chinese community sample. Journal of Psychosomatic Research2010;68:89–93.
34.
WareJEJrSherbourneCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care1992;30:473–483.
35.
KhaldoonNNanH. Comparative assessment of structural equation modeling and multiple regression research methodologies: E-commerce context. Tourism Management2010;31:314–324.
36.
PreljevicVTOsthusTBSandvikLBringagerCBOpjordsmoenSNordhusIHOsIDammenT. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. General Hospital Psychiatry2011;33:454–461.
37.
MontinaroVIaffaldanoGPGranataSPorcelliPTodarelloOSchenaFPPertosaG. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clinical Nephrology2010;73:36–43.
38.
SonikianMMetaxakiPPapavasileiouDBoufidouFNikolaouCVlassopoulosDVlahakosDV. Effects of interleukin-6 on depression risk in dialysis patients. American Journal of Nephrology2010;31:303–308.
39.
KalenderBDervisogluESengulEOzdemirACAkhanSCYalugIUzunH. Depression, nutritional status, and serum cytokines in peritoneal dialysis patients: Is there a relationship?Peritoneal Dialysis International2007;27:593–595.
40.
DervisogluEKirHMKalenderBEraldemirCCaglayanC. Depressive symptoms and proinflammatory cytokine levels in chronic renal failure patients. Nephron Clinical Practice2008;108:c272–c277.
41.
BlumeJDouglasSDEvansDL. Immune suppression and immune activation in depression. Brain, Behavior, and Immunity2011;25:221–229.
42.
IbrahimSEl SalamonyO. Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. American Journal of Nephrology2008;28:784–791.
43.
HuangTL. Lower serum albumin levels in patients with mood disorders. Chang Gung Medical Journal2002;25:509–513.
44.
MemoliBMinutoloRBisestiVPostiglioneLContiAMarzanoLCapuanoAAndreucciMBallettaMMGuidaBTettaC. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. American Journal of Kidney Diseases2002;39:266–273.
45.
BossolaMCiciarelliCDi StasioEConteGLVulpioCLucianiGTazzaL. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. General Hospital Psychiatry2010;32:125–131.
46.
GabbayVKleinRGGuttmanLEBabbJSAlonsoCMNishawalaMKatzYGaiteMRGonzalezCJ. A preliminary study of cytokines in suicidal and non-suicidal adolescents with major depression. Journal of Child and Adolescent Psychopharmacology2009;19:423–430.
47.
JhambMArgyropoulosCSteelJLPlantingaLWuAWFinkNEPoweNRMeyerKBUnruhML. Correlates and outcomes of fatigue among incident dialysis patients. Clinical Journal of the American Society of Nephrology2009;4:1779–1786.
48.
KalenderBOzdemirACDervisogluEOzdemirO. Quality of life in chronic kidney disease: Effects of treatment modality, depression, malnutrition and inflammation. International Journal of Clinical Practice2007;61:569–576.
49.
LoftisJMHuckansMMorascoBJ. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiology of Disease2010;37:519–533.
50.
LeeSKLeeHSLeeTBKimDHKooJRKimYKSonBK. The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients. Journal of Korean Medical Science2004;19:384–389.
